Filing Details
- Accession Number:
- 0001181431-11-029074
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-12 12:48:16
- Reporting Period:
- 2011-05-10
- Filing Date:
- 2011-05-12
- Accepted Time:
- 2011-05-12 12:48:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1321178 | Moshe Arkin | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-05-10 | 78,553 | $87.52 | 5,571,399 | No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
| Common Stock | Disposition | 2011-05-11 | 50,175 | $87.24 | 5,521,224 | No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
| No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,130 | Direct |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $87.50 to $87.88. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $87.08 to $87.89. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
